AUS Edition 
NZ Edition 
UK Edition 
CA Edition 
USA Edition 
FRA Edition 
GER Edition 
ESP Edition 
ITA Edition 
NLD Edition 
PRT Edition 
SWE Edition 
GRC Edition 
IND Edition 
POL Edition 
BRA Edition 
ZAF Edition 
RUS Edition 
CHN Edition 
UAE Edition 
⚠
✓
Accolade Inc (NASDAQ:ACCD)
-- USD
0.000 0.000%Sponsored Reports
Loading...
| Previous Close (in USD) | -- |
|---|---|
| Change | 0.000 0.000% |
| 52 W H/L (in USD) | 15.360/3.080 |
| EBITDA (in USD) | -53.619M |
| PE Ratio | -- |
| Volume | -- |
| Diluted Eps TTM | -1.02 |
| Total Assets (in USD) | 788.151M |
|---|---|
| Total Liabilities (in USD) | 342.686M |
| Revenue TTM (in USD) | 441.028M |
| Cash (in USD) | 185.718M |
| Market Cap (in USD) | 291.544 M |
| Revenue Per Share TTM | 5.706 |
| Gross Profit TTM (in USD) | 165.262M |
Summary
Income Statement
Balance Sheet
Change in Cash
Operating Cash
Accolade Inc
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Employees: 2400
Key Executives
| Sr. No. | Name | Title | Year Born |
|---|---|---|---|
| 1. | Mr. Rajeev Singh | Chairman & CEO | 1968 |
| 2. | Mr. Robert Cavanaugh | Pres | 1969 |
| 3. | Mr. Stephen H. Barnes CPA | CFO & Treasurer | 1972 |
| 4. | Mr. Michael W. Hilton | Chief Innovation Officer | 1965 |
| 5. | Mr. Todd Friedman | Sr. VP of Investor Relations | NA |
| 6. | Mr. Richard Eskew | EVP, Gen. Counsel, CCO & Sec. | NA |
| 7. | Ms. Carolina Lobo | Chief Marketing Officer | NA |
| 8. | Ms. Kristen Keating Weeks | VP of Strategy, Corp. Devel. & Partnerships | NA |
| 9. | Ms. Jennifer Hanson | Exec. VP of People and Culture & Chief HR Officer | NA |
| 10. | Mr. Todd Clardy | Exec. VP & GM of Mid-Market Bus. | NA |
Peers
Sector: Healthcare
Industry: Health Information Services
| Company | Change (USD) | Price (USD) | Trailing PE(x) | Forward PE(x) | Price Sales TTM(x) | Price to Book Value(x) | Enterprise Value to Revenue(x) | Enterprise Value to EBITDA(x) |
|
GEHC
GE HealthCare Technologies Inc. |
+0.780 1.096% | 71.58 | 22.910 | 20.121 | 2.014 | 5.519 | 2.390 | 13.304 |
|
VEEV
Veeva Systems Inc Class A |
+2.155 0.769% | 281.85 | 54.610 | 33.223 | 12.830 | 6.727 | 11.138 | 58.844 |
|
MTHRF
M3 Inc |
0.000 0.000% | 13.65 | 29.720 | 25.000 | 0.046 | 4.379 | 0.041 | 0.118 |
|
MTHRY
M3 Inc |
+0.021 0.310% | 6.77 | 31.840 | 26.247 | 0.047 | 4.597 | 0.041 | 0.118 |
Income Statement
(Currency in USD)| Breakdown | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 | 28-02-2019 |
|---|---|---|---|---|---|
| Income Before Tax | -463.274M | -128.763M | -50.648M | -51.236M | -56.441M |
| Minority Interest | - | - | - | - | - |
| Net Income | -459.65M | -123.124M | -50.652M | -51.365M | -56.496M |
| Selling General Administrative | 81.209M | 99.106M | 31.584M | 26.154M | 19.665M |
| Gross Profit | 164.237M | 141.002M | 76.685M | 58.822M | 34.243M |
| Reconciled Depreciation | 46.377M | 42.608M | 8.212M | 8.516M | 9.391M |
| Ebit | 135.896M | -171.141M | -46.777M | -48.204M | -54.067M |
| Ebitda | 182.273M | -128.666M | -38.712M | -39.795M | -44.676M |
| Depreciation And Amortization | 46.377M | 42.475M | 8.065M | 8.409M | 9.391M |
| Operating Income | 135.896M | -171.141M | -46.777M | -48.204M | -53.977M |
| Other Operating Expenses | 526.951M | 481.162M | 217.135M | 180.711M | 148.788M |
| Interest Expense | 0.255M | 2.905M | 3.724M | 2.925M | 2.374M |
| Tax Provision | -3.624M | -5.639M | 0.004M | 0.129M | 0.055M |
| Interest Income | 0.255M | - | - | - | 2.374M |
| Net Interest Income | 0.255M | -2.905M | -3.724M | -2.925M | -2.374M |
| Income Tax Expense | -3.624M | -5.639M | 0.004M | 0.129M | 0.055M |
| Total Revenue | 363.142M | 310.021M | 170.358M | 132.507M | 94.811M |
| Total Operating Expenses | 328.046M | 312.143M | 123.462M | 107.026M | 88.22M |
| Cost Of Revenue | 198.905M | 169.019M | 93.673M | 73.685M | 60.568M |
| Total Other Income Expense Net | -599.17M | 42.378M | -3.871M | -3.032M | -0.09M |
| Net Income From Continuing Ops | -459.65M | -123.124M | -50.652M | -51.365M | -56.496M |
| Net Income Applicable To Common Shares | -459.65M | -123.124M | -50.652M | -51.365M | -56.496M |
Balance Sheet
(Currency in USD)| Breakdown | 29-02-2024 | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 |
|---|---|---|---|---|---|
| Total Assets | 788.151M | 903.069M | 1285.529M | 475.51M | 124.414M |
| Intangible Assets | 165.407M | 203.202M | 244.69M | 0.604M | 2.054M |
| Other Current Assets | 15.808M | 14.149M | 9.468M | 5.957M | 12.944M |
| Total Liab | 342.686M | 429.283M | 429.735M | 84.662M | 148.187M |
| Total Stockholder Equity | 445.465M | 473.786M | 855.794M | 390.848M | -23.773M |
| Other Current Liab | 52.242M | 51.09M | 50.189M | 40.791M | 31.092M |
| Common Stock | 0.008M | 0.007M | 0.007M | 0.006M | 0.004M |
| Capital Stock | 0.008M | 0.007M | 0.007M | 0.006M | 0.004M |
| Retained Earnings | -1054.099M | -954.294M | -494.644M | -371.52M | -320.868M |
| Good Will | 278.191M | 278.191M | 577.896M | 4.013M | 4.013M |
| Other Assets | 0M | - | 8.883M | 7.685M | 4.621M |
| Cash | 185.718M | 321.083M | 365.853M | 433.884M | 84.321M |
| Cash And Equivalents | - | - | - | - | - |
| Total Current Liabilities | 107.85M | 119.414M | 111.753M | 79.075M | 69.958M |
| Current Deferred Revenue | 34.77M | 50.885M | 47.138M | 30.894M | 33.593M |
| Net Debt | 55.93M | -4.287M | -46.112M | -433.884M | -12.011M |
| Short Term Debt | 7.089M | 7.284M | 6.589M | - | - |
| Short Long Term Debt | 0.438M | 0.596M | 0.596M | - | - |
| Short Long Term Debt Total | 241.648M | 316.796M | 319.741M | - | 72.31M |
| Other Stockholder Equity | 1499.603M | 1428.073M | 1350.431M | 762.362M | 297.091M |
| Property Plant Equipment | - | 14.763M | 11.797M | 9.227M | 13.625M |
| Total Current Assets | 280.543M | 365.949M | 409.137M | 453.981M | 100.101M |
| Long Term Investments | - | - | - | - | - |
| Short Term Investments | 51.315M | - | - | - | - |
| Net Receivables | 27.702M | 26.695M | 30.801M | 11.837M | 1.189M |
| Long Term Debt | 208.482M | 282.323M | 280.666M | - | 72.31M |
| Inventory | 0M | 4.022M | 3.015M | 2.303M | 1.647M |
| Accounts Payable | 13.749M | 10.155M | 7.837M | 7.39M | 5.273M |
| Accumulated Other Comprehensive Income | -0.047M | - | - | -475.51M | -50.608M |
| Non Currrent Assets Other | 16.53M | 11.439M | 8.883M | 7.685M | 4.621M |
| Non Current Assets Total | 507.608M | 537.12M | 876.392M | 21.529M | 24.313M |
| Capital Lease Obligations | 32.728M | 34.473M | 39.075M | - | - |
| Long Term Debt Total | - | 282.323M | 280.666M | - | - |
Cash Flow
(Currency in USD)| Breakdown | 28-02-2023 | 28-02-2022 | 28-02-2021 | 29-02-2020 | 28-02-2019 |
|---|---|---|---|---|---|
| Investments | -7.228M | -263.613M | -2.423M | -3.521M | -3.118M |
| Total Cashflows From Investing Activities | -7.228M | -263.613M | -2.423M | -3.521M | -3.118M |
| Total Cash From Financing Activities | 3.163M | 257.932M | 428.384M | 28.222M | 48.833M |
| Net Income | -459.65M | -123.124M | -50.652M | -51.365M | -56.496M |
| Change In Cash | -44.77M | -68.031M | 400.729M | -9.546M | 29.167M |
| Begin Period Cash Flow | 365.853M | 433.884M | 33.155M | 42.701M | 13.534M |
| End Period Cash Flow | 321.083M | 365.853M | 433.884M | 33.155M | 42.701M |
| Total Cash From Operating Activities | -40.705M | -62.35M | -25.232M | -34.247M | -16.548M |
| Depreciation | 46.377M | 42.608M | 8.212M | 8.516M | 9.391M |
| Other Cashflows From Investing Activities | -5.123M | -261.092M | -0.432M | -0.058M | -0.058M |
| Dividends Paid | - | - | - | - | - |
| Change To Inventory | - | - | 7.657M | - | - |
| Sale Purchase Of Stock | 4.991M | 13.243M | 451.137M | - | 50.935M |
| Other Cashflows From Financing Activities | 3.163M | -189.286M | 62.893M | -3.521M | 53.935M |
| Capital Expenditures | 7.228M | 3.617M | 2.365M | 3.315M | 3.118M |
| Change In Working Capital | -1.142M | -7.843M | 3.723M | -5.402M | 23.842M |
| Other Non Cash Items | 305.063M | -40.798M | 3.909M | 1.819M | 0.425M |
| Free Cash Flow | -47.933M | -65.967M | -27.597M | -37.562M | -19.666M |
Funds
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | ARK Genomic Revolution | 8 months ago | 5347280 |
| 2. | ARK Genomic Revolution ETF | 6 months ago | 5018455 |
| 3. | Vanguard Total Stock Mkt Idx Inv | 7 months ago | 2213022 |
| 4. | iShares Russell 2000 ETF | 6 months ago | 1993350 |
| 5. | Nikko AM ARK Pstv Chg Innovt P JPY Acc | 7 months ago | 1152356 |
| 6. | Vanguard Institutional Extnd Mkt Idx Tr | 7 months ago | 1134200 |
| 7. | Nikko Gbl All Biological Genome Eq MF | 1 year ago | 836635 |
| 8. | Fidelity Small Cap Index | 8 months ago | 742028 |
| 9. | Bellevue (Lux) Bellevue Dgtl Hthl I2 EUR | 7 months ago | 640865 |
| 10. | Kennedy Micro Cap | 8 months ago | 575730 |
| 11. | iShares Russell 2000 Value ETF | 6 months ago | 476535 |
| 12. | State St Russell Sm/Mid Cp® Indx NL Cl C | 7 months ago | 447749 |
| 13. | Fidelity Extended Market Index | 7 months ago | 412434 |
| 14. | Schwab US Small-Cap ETF™ | 6 months ago | 355768 |
| 15. | DFA US Targeted Value I | 7 months ago | 337722 |
| 16. | Vanguard Russell 2000 ETF | 7 months ago | 330755 |
| 17. | SPDR® S&P Kensho New Economies Comps ETF | 6 months ago | 290197 |
| 18. | Fidelity Tactical High Income Sr F8 | 1 year ago | 249405 |
| 19. | Dimensional US Targeted Value ETF | 6 months ago | 244837 |
| 20. | State St Russell Sm Cap® Indx SL Cl I | 6 months ago | 239632 |
Institutions
| Sr. No. | Name | Purchased On | Shares |
|---|---|---|---|
| 1. | BlackRock Inc | 11 months ago | 6158674 |
| 2. | ARK Investment Management LLC | 8 months ago | 5382533 |
| 3. | Brown Advisory Holdings Inc | 8 months ago | 4824662 |
| 4. | Millennium Management LLC | 8 months ago | 3987883 |
| 5. | Deerfield Management Co | 8 months ago | 3475000 |
| 6. | Prosight Management, LP | 8 months ago | 2801598 |
| 7. | Nikko Asset Management Americas Inc | 11 months ago | 2011931 |
| 8. | State Street Corp | 8 months ago | 1927089 |
| 9. | Sumitomo Mitsui Trust Group Inc | 8 months ago | 1890123 |
| 10. | Geode Capital Management, LLC | 8 months ago | 1782038 |
| 11. | Clearline Capital LP | 8 months ago | 1539578 |
| 12. | Dimensional Fund Advisors, Inc. | 8 months ago | 1509390 |
| 13. | D. E. Shaw & Co LP | 8 months ago | 1282360 |
| 14. | Fairman Group LLC | 8 months ago | 1137287 |
| 15. | Jane Street Group LLC | 11 months ago | 1005145 |
| 16. | Whetstone Capital Advisors, LLC | 8 months ago | 997889 |
| 17. | Kennedy Capital Management Inc | 8 months ago | 756556 |
| 18. | Bellevue Group AG | 8 months ago | 640865 |
| 19. | Point72 Asset Management, L.P. | 8 months ago | 617579 |
| 20. | Vanguard Group Inc | 8 months ago | 4157154 |
Data Powered by EOD Historical Data (“EODHD”). All CFDs (stocks, indices, mutual funds, ETFs), and Forex are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. EODHD is not using exchanges data feeds for the pricing data, EODHD is using OTC, peer to peertrades and trading platforms over 100+ sources, EODHD is aggregating its data feeds via VWAP method. Therefore, EOD Historical Data doesn’t bear any responsibility for any trading losses you might incur as a result of using this data. EOD Historical Data or anyone involved with EOD Historical Data will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible. EOD Historical Data does not give any warranties (including, without limitation, as to merchantability or fitness for a particular purpose or use).
Sponsored Articles
Loading...
Related Articles
Loading...